Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis

T Fiolet, A Guihur, ME Rebeaud, M Mulot… - Clinical microbiology …, 2021 - Elsevier
Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …

Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis

Z Kashour, M Riaz, MA Garbati… - Journal of …, 2021 - academic.oup.com
Objectives Clinical studies of chloroquine (CQ) and hydroxychloroquine (HCQ) in COVID-19
disease reported conflicting results. We sought to systematically evaluate the effect of CQ …

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

L Catteau, N Dauby, M Montourcy, E Bottieau… - International journal of …, 2020 - Elsevier
Hydroxychloroquine (HCQ) has been largely used and investigated as therapy for COVID-
19 across various settings at a total dose usually ranging from 2400 mg to 9600 mg. In …

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019

P Bansal, A Goyal, A Cusick Iv, S Lahan… - Annals of …, 2021 - Taylor & Francis
Hydroxychloroquine, initially used as an antimalarial, is used as an immunomodulatory and
anti-inflammatory agent for the management of autoimmune and rheumatic diseases such …

National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: Version 1

JM Gelfand, AW Armstrong, S Bell, GL Anesi… - Journal of the American …, 2020 - Elsevier
Objective To provide guidance about management of psoriatic disease during the
coronavirus disease 2019 (COVID-19) pandemic. Study design A task force (TF) of 18 …

Update alert 3: hydroxychloroquine or chloroquine for the treatment or prophylaxis of COVID-19

AV Hernandez, YM Roman, V Pasupuleti… - Annals of internal …, 2020 - acpjournals.org
This report, the third update of a previously published living systematic review (1), focuses
on treatment (not prophylaxis) of coronavirus disease 2019 (COVID-19) with …

Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis

M Wang, T Wu, Z Zuo, Y You, X Yang… - BMJ supportive & …, 2021 - spcare.bmj.com
Background Because of the lack of vaccination, it is urgent to find effective antiviral agents
for COVID-19 treatment. Method Online databases were searched for articles published …

[HTML][HTML] Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review

C Prodromos, T Rumschlag - New microbes and new infections, 2020 - Elsevier
Hydroxychloroquine (HCQ) has shown efficacy against coronavirus disease 2019 (COVID-
19) in some but not all studies. We hypothesized that a systematic review would show HCQ …

A causal framework to determine the effectiveness of dynamic quarantine policy to mitigate COVID-19

W Kristjanpoller, K Michell, MC Minutolo - Applied Soft Computing, 2021 - Elsevier
Since the start of the pandemic caused by the novel coronavirus, COVID-19, more than 106
million people have been infected and global deaths have surpassed 2.4 million. In Chile …

The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients

L Ayerbe, C Risco-Risco, S Ayis - Internal and Emergency Medicine, 2020 - Springer
This study investigates the association between the treatment with hydroxychloroquine and
mortality in patients admitted with COVID-19. Routinely recorded, clinical data, up to the 24th …